S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
South Korean doctors hold massive anti-government rally over medical school recruitment plan
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
South Korean doctors hold massive anti-government rally over medical school recruitment plan
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
South Korean doctors hold massive anti-government rally over medical school recruitment plan
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
South Korean doctors hold massive anti-government rally over medical school recruitment plan
ETR:SBS

Stratec (SBS) Stock Price, News & Analysis

€43.10
+1.15 (+2.74%)
(As of 03/1/2024 ET)
Today's Range
€42.00
€43.40
50-Day Range
€40.50
€45.55
52-Week Range
€36.00
€78.50
Volume
4,740 shs
Average Volume
6,253 shs
Market Capitalization
$524.10 million
P/E Ratio
43.54
Dividend Yield
2.25%
Price Target
€78.75

Stratec MarketRank™ Stock Analysis

Analyst Rating
0.00 Rating Score
Upside/​Downside
82.7% Upside
€78.75 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.73 out of 5 stars


SBS stock logo

About Stratec Stock (ETR:SBS)

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. The company operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput segment. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

SBS Stock Price History

SBS Stock News Headlines

Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
EQS-News: STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2023
Stratec's (ETR:SBS) Returns Have Hit A Wall
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
EQS-News: STRATEC POSTS FINAL RESULTS FOR FIRST HALF OF 2023
STRATEC COMPLETES ACQUISITION OF NATECH PLASTICS
Is Stratec SE (ETR:SBS) Trading At A 37% Discount?
Stratec SE (SBS.DU)
EQS-News: STRATEC REPORTS FINAL FIGURES FOR 2022 FINANCIAL YEAR
See More Headlines
Receive SBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stratec and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
1,532
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
€78.75
High Stock Price Target
€87.00
Low Stock Price Target
€71.00
Potential Upside/Downside
+82.7%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$12.03 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$254.65 million
Cash Flow
€1.81 per share
Book Value
€18.58 per share

Miscellaneous

Free Float
N/A
Market Cap
$524.10 million
Optionable
Not Optionable
Beta
0.14
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Marcus Wolfinger (Age 57)
    Chairman of Board of Management & CEO
    Comp: $1.13M
  • Dr. Robert Siegle (Age 57)
    Director of Finance & Human Resources and Member of Board of Management
    Comp: $914k
  • Dr. Claus Vielsack (Age 57)
    Director of Product Development & Member of Board of Management
    Comp: $710k
  • Mr. Hermann Leistner (Age 78)
    Founder & Advisor
  • Dr. Georg Bauer (Age 51)
    Member of Management Board
  • Mr. Jan Keppeler
    Head of Investor Relations, Sustainability & Corporate Communications
  • Mr. Roland Utz
    Head of Supply Chain Management & Senior VP














SBS Stock Analysis - Frequently Asked Questions

What is Stratec's stock price target for 2024?

0 analysts have issued 1 year price targets for Stratec's stock. Their SBS share price targets range from €71.00 to €87.00. On average, they expect the company's share price to reach €78.75 in the next twelve months. This suggests a possible upside of 82.7% from the stock's current price.
View analysts price targets for SBS
or view top-rated stocks among Wall Street analysts.

How have SBS shares performed in 2024?

Stratec's stock was trading at €45.55 on January 1st, 2024. Since then, SBS stock has decreased by 5.4% and is now trading at €43.10.
View the best growth stocks for 2024 here
.

Is Stratec a good dividend stock?

Stratec (ETR:SBS) pays an annual dividend of €0.97 per share and currently has a dividend yield of 2.16%. The dividend payout ratio is 97.98%. Payout ratios above 75% are not desirable because they may not be sustainable.

What other stocks do shareholders of Stratec own?
This page (ETR:SBS) was last updated on 3/3/2024 by MarketBeat.com Staff